CLISTIN Trademark

Trademark Overview

On Wednesday, September 16, 2020, a trademark application was filed for CLISTIN with the United States Patent and Trademark Office. The USPTO has given the CLISTIN trademark a serial number of 90185968. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 3, 2024. This trademark is owned by Melbourne Laboratories LLC. The CLISTIN trademark is filed in the Pharmaceutical Products category with the following description:

Antihistamine preparations
clistin

General Information

Serial Number90185968
Word MarkCLISTIN
Filing DateWednesday, September 16, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 2, 2021

Trademark Statements

Goods and ServicesAntihistamine preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 26, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMelbourne Laboratories LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMountain View, CA 94040
Party NameMelbourne Laboratories LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMountain View, CA 94040

Trademark Events

Event DateEvent Description
Saturday, September 19, 2020NEW APPLICATION ENTERED
Monday, October 26, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 27, 2021ASSIGNED TO EXAMINER
Wednesday, January 27, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 2, 2021PUBLISHED FOR OPPOSITION
Tuesday, March 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 27, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, October 1, 2021SOU TEAS EXTENSION RECEIVED
Friday, October 1, 2021SOU EXTENSION 1 FILED
Friday, October 1, 2021SOU EXTENSION 1 GRANTED
Tuesday, October 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 28, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, March 29, 2023SOU TEAS EXTENSION RECEIVED
Friday, April 1, 2022SOU TEAS EXTENSION RECEIVED
Friday, April 1, 2022SOU EXTENSION 2 FILED
Friday, April 1, 2022SOU EXTENSION 2 GRANTED
Wednesday, September 28, 2022SOU EXTENSION 3 FILED
Wednesday, September 28, 2022SOU EXTENSION 3 GRANTED
Friday, September 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 29, 2023SOU EXTENSION 4 FILED
Wednesday, March 29, 2023SOU EXTENSION 4 GRANTED
Monday, September 25, 2023SOU TEAS EXTENSION RECEIVED
Monday, September 25, 2023SOU EXTENSION 5 FILED
Tuesday, October 3, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 3, 2023SOU EXTENSION 5 GRANTED
Monday, June 3, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, July 12, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, October 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 31, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

clistin preparations antihistamine